Accounting for assay performance when estimating the temporal dynamics in SARS-CoV-2 seroprevalence in the U.S.

Reconstructing the incidence of SARS-CoV-2 infection is central to understanding the state of the pandemic. Seroprevalence studies are often used to assess cumulative infections as they can identify asymptomatic infection. Since July 2020, commercial laboratories have conducted nationwide serosurvey...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Carreras, Bernardo, Hitchings, Matt D. T., Johansson, Michael A., Biggerstaff, Matthew, Slayton, Rachel B., Healy, Jessica M., Lessler, Justin, Quandelacy, Talia, Salje, Henrik, Huang, Angkana T., Cummings, Derek A. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115837/
https://www.ncbi.nlm.nih.gov/pubmed/37076502
http://dx.doi.org/10.1038/s41467-023-37944-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10115837/
https://www.ncbi.nlm.nih.gov/pubmed/37076502
http://dx.doi.org/10.1038/s41467-023-37944-5

Ejemplares similares